Welcome to our dedicated page for PALOMA ACQUISITION I news (Ticker: PALOU), a resource for investors and traders seeking the latest updates and insights on PALOMA ACQUISITION I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PALOMA ACQUISITION I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PALOMA ACQUISITION I's position in the market.
Paloma Acquisition Corp I (NASDAQ: PALOU) closed its initial public offering on February 20, 2026, selling 15,000,000 units at $10.00 per unit for total gross proceeds of $150 million. Each unit includes one Class A ordinary share and one-half warrant; whole warrants exercise at $11.50 per share. Units began trading on Nasdaq under PALOU on February 19, 2026, and once separated the shares and warrants are expected to list as PALO and PALOW.
Jefferies acted as sole book-running manager and a registration statement became effective February 18, 2026.
Paloma Acquisition Corp I (NASDAQ:PALOU) priced an initial public offering of 15,000,000 units at $10.00 per unit for gross proceeds of $150,000,000. Units begin trading on the Nasdaq Global Market under PALOU on February 19, 2026, and the offering is expected to close February 20, 2026.
Each unit comprises one Class A ordinary share and one-half of a redeemable warrant; whole warrants exercise at $11.50. The company targets acquisitions in the minerals sector focused on U.S. gold and silver. Jefferies LLC is sole book-running manager; underwriters have a 45-day option to buy 2,250,000 additional units.